# Christoph Wanner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christoph-wanner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 104,723 |
| Field | Diabetes Treatment and Management |
| h-index | 135 |
| i10-index | 692 |
| Last Known Institution | Universitätsklinikum Würzburg |
| OpenAlex ID | https://openalex.org/A5033368647 |
| ORCID iD | 0000-0001-9507-5301 |
| Works | 1,289 |

## Researcher papers

Showing 12 of 55.

- [Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-cardiovascular-outcomes-and-mortality-in-type-2-diabetes/)
- [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice](https://scholariq.org/papers/2021-esc-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-and-progression-of-kidney-disease-in-type-2-diabetes/)
- [2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension](https://scholariq.org/papers/2023-esh-guidelines-for-the-management-of-arterial-hypertension-the-task-force/)
- [Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis](https://scholariq.org/papers/atorvastatin-in-patients-with-type-2-diabetes-mellitus-undergoing-hemodialysis/)
- [A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease](https://scholariq.org/papers/a-proposed-nomenclature-and-diagnostic-criteria-for-protein-energy-wasting-in/)
- [Review on uremic toxins: Classification, concentration, and interindividual variability](https://scholariq.org/papers/review-on-uremic-toxins-classification-concentration-and-interindividual/)
- [Inflammation enhances cardiovascular risk and mortality in hemodialysis patients](https://scholariq.org/papers/inflammation-enhances-cardiovascular-risk-and-mortality-in-hemodialysis-patients/)
- [KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2022-clinical-practice-guideline-for-diabetes-management-in-chronic-kidney/)
- [Chronic kidney disease and the global public health agenda: an international consensus](https://scholariq.org/papers/chronic-kidney-disease-and-the-global-public-health-agenda-an-international/)
- [Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk](https://scholariq.org/papers/effect-of-linagliptin-vs-placebo-on-major-cardiovascular-events-in-adults-with/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Lysosomal Storage Disorders Research](https://scholariq.org/topics/lysosomal-storage-disorders-research/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [Universitätsklinikum Würzburg](https://scholariq.org/institutions/universitatsklinikum-wurzburg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.